Avonisys AG: Avonisys AG wins patent litigation case against Synova SA
7.4.2021 15:36:04 CEST | news aktuell GmbH | Press release
(Zug, Switzerland):
- Swiss Federal Patent Court confirms: no infringement of Synova’s CH/EP 1833636 H1 (partial renunciation of EP1833636B1 in Switzerland)
- Synova is convicted under the unfair competition act (UWG)
- Synova has to cover 80% of the costs of the court case
Zug, 07.04.2021/PR
With its verdict released on March 31, 2021, the Swiss Federal Patent Court concluded that Avonisys’ patented Air-Jet technology does not infringeSynova’s CH/EP 1833636 H1. During the proceedings, Synova felt compelled to partially waive the original Swiss part of the patent in suit (EP 1833636 B1) and to substantially limit the scope of the patent claims to avoid patent invalidation following significant prior art brought up by Avonisys AG.
“We clearly appreciate the court’s decision which confirms our view that the Air-Jet feature stands in its own right and does not infringe. Our patented Air-Jet is one of the key innovations Avonisys has contributed to the waterjet laser technology, establishing a new and unmatched performance benchmark”, comments Jens Gaebelein, one of the founders and CTO of Avonisys.
Furthermore, the verdict holds that Synova violated the Unfair Competition Act (UWG) by approaching market participants with misleading information and unfounded threats relating to the infringement proceedings. The verdict demands Synova to release corrective information to every party contacted previously. Continuing such misleading activities in the future would result in fines against Synova.
“From the start in 2013, it has been Avonisys’ policy to build a solid IP base for its innovative hardware and process technology, which is underlined by more than 30 validated patents. We defend our technology vigorously against unfounded allegations. Customers around the globe value the reliability and ease-of-use of our products and appreciate to have a choice”, adds Jeroen Hribar, co-founder and CSO of Avonisys.
The verdict is subject to a 30 day recourse period for the parties and only then will be firm and final.
About Avonisys AG:
Avonisys develops, builds and sells laser systems based on its proprietary waterjet laser technology. Avonisys’ systems are designed to deliver robust performance for demanding applications while keeping operations simple and maintenance cost-effective.
- Picture is available at AP Images (http://www.apimages.com) -
Contacts
Dr. Stephan Mohren
Chairman of the Board
General-Guisan-Strasse 6
6300 Zug, Switzerland
Tel: +41 (0) 41 229 48 73
smohren@avonisys.com
Links
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
FEV collaborates with Microsoft on efficient AI model approach for in car applications built on NVIDIA9.7.2026 11:05:00 CEST | Press release
Aachen – FEV is collaborating with Microsoft to integrate powerful, in-vehicle Generative AI capabilities built on NVIDIA GPU-accelerated compute and AI model microservices. The cooperation aims to enable multimodal voice, text, and gesture interactions directly in the vehicle – independent of a permanent Internet connection.
Acrobat Studio og Acrobat KI-assistent: den nye generasjonen KI-støttet produktivitet – nå også på norsk8.7.2026 15:08:48 CEST | Press release
SAN JOSE, Calif. - 8. juli 2026 - Adobe utvider tilgjengeligheten til Acrobat Studio og Acrobat KI-assistenten i Norge. Nå er de KI-støttede funksjonene for produktivitet og kreavtivitet også tilgjengelige på norsk, og kan dermed brukes av brukere på lokalt språk. Acrobat Studio kombinerer Adobe Acrobat Pro, Adobe Express Premium og smarte KI-assistenter. Acrobat KI-assistent er også tilgjengelig som et separat tillegg for alle Adobe Acrobat-produkter (Acrobat Reader, Acrobat Standard og Acrobat Pro) – et fleksibelt alternativ for alle som ønsker å bruke KI-støttede funksjoner kun når de arbeider med dokumenter. Begge disse tilbudene gjør det mulig for brukere å raskere samle inn informasjon i PDF-er og Office-dokumenter, opprette innhold og effektivisere arbeidsflyten. Acrobat Studio og Acrobat KI-assistenten markerer et viktig trinn i utviklingen av PDF-filen, som har blitt standarden for viktige dokumenter siden den ble lansert av Adobe i 1993. Acrobat utvikler seg fra et ledende pr
Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy8.7.2026 10:37:04 CEST | Press release
Aachen, 08 July 2026 – Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD).
Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist29.6.2026 12:28:23 CEST | Press release
The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. A Phase II trial will commence later this year.
FRITZ: YouGov survey in 14 countries: Trust in router manufacturers from different regions European consumers mistrust Chinese routers29.6.2026 10:00:00 CEST | Press release
More than half of consumers in Norway mistrust routers from Chinese manufacturers (59%) Many mistrust devices made in the USA European routers enjoy a high level of trust across Europe (60%) For half of Europeans (55%), the ‘Made in Europe’ label important to when making a purchase
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom

